Last: $0.72 Up: $0.22
Percentage: 44% Vol. 3.3M
Hub On AGORACOM / Corporate Profile / Corporate Website
———————
Last: $0.46 Up: $0.10
Percentage: 27.78% Vol. 284K
Hub On AGORACOM / Corporate Profile / Corporate Website
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Good morning to you all.  As the Small Cap Medical Marijuana Stocks race enters its infancy “PotCom” … but sets to become the single fastest growing industry since DotCom, AGORACOM will once again establish itself as the starting point for investor research and moderated discussion.
We’ve already started the process by announcing the engagement of 3 leading small cap medical marijuana clients:
We’re now building on that foundation by launching the AGORACOM Small Cap Marijuana Stocks Gateway. Â This is the research starting point for small cap marijuana stocks investors to begin their research. Â We feel it is important to help investors given the fact that we have already seen – and expect to see many more – “pretenders” enter the space by simply issuing a press release with “medical marijuana” in it for no other reason than to get a quick bump in their share price.
Our gateway will only include real small cap medical marijuana companies that are truly engaged in the business and have taken active steps towards it. Â In addition, the gateway goes beyond being a simple list by actively updating itself with relevant content from the industry.
Within a few weeks, this initiative will grow even further with a bigger presence and even greater content but – in the meantime – we believe this is a great starting point to discover real small cap marijuana stocks.
Click below to start your research and be sure to come back often!
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
MICHEL COMTE / AFP/GETTY IMAGES
Tweed Inc. workers tend to medical marijuana plants at a new commercial operation set up inside a former Hershey’s chocolate factory in Smiths Falls, Ontario, an hour’s drive from Canada’s capital Ottawa, on February 4, 2014. AFP PHOTO/MICHEL COMTE
Canada’s new medical marijuana industry is set to make history on the Toronto Stock Exchange.
Tweed Inc., among the first ten companies licensed by the federal government to produce and distribute pot, is in the final stages of approval for a listing on the TSX Venture Exchange.
The firm has a ticker secured — TWD — chosen because fertilizer manufacturer Potash Corp. has long held the ticker POT, joked chairman Bruce Linton.
If it is granted the listing it will become the country’s first public medical marijuana company with an opening share price just below $1, he said.
With over $10 million in private financing, Tweed is housed in the old Hershey’s plant in Smiths Falls and on track to produce 25 different strains of medical marijuana ranging in price from $5 to $12 a gram.
The company hopes to capture a healthy slice of the $1.3-billion medical marijuana industry Health Canada forecasts by 2024. And that’s worth the scrutiny and paperwork of an IPO, said Linton.
“We thought it was an important step to give another level of credibility to what we’re doing as a differentiator in terms of professionalism,†he explained.
Under Canada’s new Marihuana for Medical Purposes Regulations (MMPR), which roll out completely April 1, the government appoints and oversees producers. The old guidelines allowed users to grow their own medical marijuana or purchase it from the government.
The cost for staff and facilities to meet Health Canada’s requirements is substantial, say licensees.
“To build up a capacity to produce large quantities, and test the product, and have a quality, secure operation, that requires significant dollars,†said Bedrocan Canada CEO Marc Wayne.
“You’re moving out of the kind of handmade grow ops in days gone by. This is a much more sophisticated industry.â€
Fortunately, startup money abounds. All the approved or pending producers the Star spoke with said they’d been approached with multiple offers by financiers.
Venture capitalist Kevin O’Leary may yet be among them. In a recent CNBC appearance, the investor of Dragon’s Den fame raved about the burgeoning U.S. industry where $14 million (U.S.) of recreational pot was sold in Colorado in January.
“For me as an investor, this is like getting an opportunity to get into alcohol after prohibition just ended,†he said on Squawk Box. “This is going to be a massive multi-billion dollar business, regulated and taxed by the government…. I really like the margins in this business – it is phenomenal,†he said.
However, with these changes only happening at the state level —Washington is next to allow recreational pot — O’Leary fears running afoul of territorial rules.
“If I were to invest in two deals I’ve been looking at in Colorado right now I could run into jurisdictional problems as an investor in another state where it’s illegal,†he said.
The Montreal native needs to look closer to home.
“Since we became licensed, I’ve received quite a number of calls, both from individuals and from bankers wanting to talk to me about financing or investing or even going public,†said Neil Closner, MedReleaf CEO.
“This is an extremely exciting, interesting time for bankers in Canada, because there really isn’t a huge healthcare entrepreneurial base in this country; mostly because the government controls healthcare.â€
MedReleaf doesn’t have designs on the TSX though.
“Being a public company has its pros, but it involves a lot of work in terms of public reporting and news releases and regulations,†said Closner. “We’d rather focus on growing and treating our patients.â€
Mark Gobuty, CEO of The Peace Naturals Project, has a similar outlook: “We think there’s going to be a significant evolution for this industry. We need to be nimble and responsive, both to our clients and to the regulator, and we need to be privately held, with a low amount of shareholders, for really important decisions.â€
One publicly-traded Canadian company has their sights on ancillary industries rather than growers or producers.
“There are just a lot of companies rushing into that space,†said Harry Barr, CEO of Vancouver-based Next Gen Metals Inc. “Part of my fear is that there’s a limited amount of patients. I see us financing the companies that do the lights, the fertilizer, the seed, the sophisticated equipment that would go in there. To use a mining analogy, I want to sell them the picks and shovels.â€
The long time mining executive, who is diversifying into medical marijuana and industrial hemp to buoy a mining slump, said Next Gen is currently reviewing 45 proposals.
Source: http://www.thestar.com/business/2014/03/13/financing_abounds_for_medical_marijuana_startups.html
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
In the one-hour documentary, Gupta gets exclusive access to the journey of Vivian’s family who, along with many patients, are willing to do anything to get medical marijuana and face many legal challenges along the way. He meets with dozens of families dubbed “medical marijuana refugees” who have moved to Colorado, where pot is legal, to get medical marijuana for their sick children. Gupta also examines disparities in the U.S. government’s research into the benefits of medical marijuana and reports on groundbreaking discoveries in other countries. Gupta’s investigation takes him around the world looking for answers, including a rare inside look at a pharmaceutical company in the United Kingdom that is the only one in the world turning pot into a prescription drug.
Source: Cnn.com
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Regulated Marijuana Production
Dr. Sanjay Gupta, CNN Cheif Medical Correspondent. We have no affiliation with this well known medical expert, but his latest “Doubling Down” on the medical marijuana sector is worthy of your attention. Reasons such as these convince us we are doing the right thing in entering this market.
We are no longer your Daddy’s Oil Company
Lexaria Corp. has been in business since 2005 and for nine years explored for and developed oil and gas assets in low-risk areas of North America. Lexaria still owns oil production in Mississippi, producing oil from wells at the Belmont Lake oil field. (You can learn about that in our “Oil Operations” section) During the last three full years combined, revenue was a total of about $3,550,000.
But North American society has changed dramatically, and so have we. Our proved management team has always employed sensible risk management controls in an effort to preserve the capital entrusted by shareholders. After all, its YOUR money!
And today, most Americans and most Canadians support some form of medical use of marijuana, in poll after poll.
Lexaria also has a history of working with joint venture partners, as we’ve demonstrated over the years in Oklahoma,Mississippi, Alberta and Saskatchewan. We’re changing the sector we’re focused on, but we’re not changing our commitment to best practices; to ethical behavior; and to our investors and shareholders.
Oil and Gas Operations
The Belmont Lake Oil Field is a significant oil discovery for a company our size, and one the Company intends to develop to it to its maximum value. It is within the Frio formation.
Lexaria currently owns 13% – 50% interests in the five existing oil wells in the Belmont Lake oil discovery, which was identified using 3-D Bright Spot technology. At the time of discovery the Company owned only a 20% interest. The Company’s most recent reserve report indicates that eight (8) productive oil wells could be located at Belmont Lake.
This is low-risk development opportunity at Belmont Lake offering superb returns, despite the location in the seasonal floodplain of the Mississippi River which has presented us with challenges. Seasonal flooding of the oil field forced Lexaria and its partners to devise ways to safely and reliably produce oil 12-months per year, even if the surface location was flooded with river water. The Company installed a remote tank farm and separation facility, pipelines, and various mechanical connections. Most important of all, lifting devices were utilized that use compressed natural gas to lift the oil to the surface, allowing our wells to produce at all times.
An important goal for the Company is to unlock the secret of being able to distinguish, in advance of drilling, between Frio Oil targets and Frio Gas targets. We have begun some internal research towards this goal. The Company welcomes any research or information from outside experts towards this goal and invites your contact.
Lexaria has built significant value through our analysis of 3-D seismic covering 130,000 nearby acres. Though we do not currently have an interest in these lands, we have previously generated many drilling targets.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks